54767414NAP4001 (HALO)
A Post-authorization Safety Study to Evaluate the Incidence of and Risk Factors for Severe and Fatal Infusion-related Reactions in Participants Treated with Daratumumab (Intravenous or Subcutaneous)
Cancer Types: Multiple MyelomaLines of Therapy: Other
More details:
Practices offering this clinical trial:
HH-PRT-0001 (TISSUE 32) CORE-HH
Cancer ORigin Epigenetics-Harbinger Health - Collection of Blood and Tissue Samples From Cancer and Non-Cancer Subjects for Validation of a Novel Blood-Based Multi-Cancer Screening Test
Cancer Types: Solid Tumors, Supportive CareLines of Therapy: Other
More details: https://clinicaltrials.gov/ct2/show/NCT05435066?term=hh-prt-0001&draw=2&rank=1
Practices offering this clinical trial:
PREFER NGS Registry
PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine (PREFER)
Cancer Types: Solid TumorsLines of Therapy: 1st Line Metastatic and Locally Advanced
More details: https://clinicaltrials.gov/ct2/show/NCT05697198?term=PREFER&draw=2&rank=1
Practices offering this clinical trial:
